Atrial Fibrillation (AF) and Heart Failure With Preserved Ejection Fraction (HFpEF): Advances and Challenges

Documenti analoghi

• Outcomes Among Drug Refractory Patients With Atrial Fibrillation (AF) and Concomitant Heart Failure With Preserved Ejection Fraction (HFpEF) Treated With Catheter Ablation Versus Antiarrhythmic Drugs
  di: Abhishek J. Deshmukh, et al.
  Pubblicazione: (2026)
• Impact of Timing of Atrial Fibrillation Ablation on AF Recurrence and Clinical Outcomes in Patients With HFpEF and HFrEF
  di: Mahmoud Eisa, et al.
  Pubblicazione: (2026)
• Therapeutic Strategy for Patients With Heart Failure and Atrial Fibrillation
  di: Naoya Kataoka, et al.
  Pubblicazione: (2025)
• AF‐FLOW Global Registry Confirms Validity of Electrographic Flow Mapping as a Phenotyping Tool for Atrial Fibrillation
  di: Kent R. Nilsson, et al.
  Pubblicazione: (2025)
• The Impact of SGLT2 Inhibitors on Atrial Fibrillation Recurrence and Long‐Term Clinical Outcomes in HFrEF Patients Undergoing Cryoballoon Ablation: A New Frontier Beyond Diabetes and Heart Failure
  di: Elif Hande Ozcan Cetin, et al.
  Pubblicazione: (2025)